CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
Using Data-to-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results from a Randomized Controlled Trial
-
5 01 2024
-
-
Source: J Acquir Immune Defic Syndr. 96(1):40-50
Details:
-
Alternative Title:J Acquir Immune Defic Syndr
-
Personal Author:
-
Description:Background:
Re-engaging people with HIV (PWH) who are newly out-of-care remains challenging. Data-to-care (D2C) is a potential strategy to re-engage such individuals.
Methods:
A prospective randomized controlled trial compared a D2C strategy using a disease intervention specialist (DIS) vs standard-of-care (SOC) where 23 HIV clinics in 3 counties in Connecticut could re-engage clients using existing methods. Using a data reconciliation process to confirm being newly out-of-care, 655 participants were randomized to DIS (N=333) or SOC (N=322). HIV care continuum outcomes included re-engagement at 90 days, retention in care and viral suppression (VS) by 12 months. Multivariable regression models were used to assess factors predictive of attaining HIV care continuum outcomes.
Results:
Participants randomized to DIS were more likely to be re-engaged at 90 days (aOR=1.42, p=0.045). Independent predictors of re-engagement at 90 days were: age>40 years (aOR=1.84, p=0.012) and peri-natal HIV risk category (aOR=3.19, p=0.030). Predictors of retention at 12 months included: re-engagement at 90 days (aOR=10.31, p<0.001), drug injection HIV risk category (aOR=1.83, p=0.032), detectable HIV-1 RNA before randomization (aOR=0.40, p=0.003) and county (Hartford aOR=1.74, p=0.049; New Haven aOR=1.80, p=0.030). Predictors of VS included: re-engagement at 90 days (aOR=2.85, p<0.001), retention in HIV care (aOR=7.07, p<0.001), and detectable HIV-1 RNA pre-randomization (aOR=0.23, p<0.001).
Conclusions:
A D2C strategy significantly improved re-engagement at 90 days. Early re-engagement improved downstream benefits along the HIV care continuum like retention in care and VS at 12 months. Moreover, other factors predictive of care continuum outcomes can be used to improve D2C strategies.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:38324241
-
Pubmed Central ID:PMC11009056
-
Document Type:
-
Funding:
-
Place as Subject:
-
Volume:96
-
Issue:1
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
Supporting Files:No Additional Files
